I am a medical oncologist with a primary focus on the medical treatment of patients with gynecologic cancers. I work very closely with a team of surgeons, oncologists, and radiation therapists to determine and provide the best treatment for each patient with these diseases. My research initiatives include improving the treatment options for women with recurrent ovarian cancer and uterine sarcomas.
- Clinical Expertise: Medical Treatment of Ovarian, Endometrial, and Cervical Cancers
- Languages Spoken: English
- Education: MD, National University of Ireland, Galway (Ireland)
- Residencies: Mater Misericordiae University Hospital (Dublin, Ireland)
- Fellowships: Royal College of Physicians (Ireland); Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine (Ireland and United Kingdom); Medical Oncology (Ireland and Europe)
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Roisin E. O'Cearbhaill
- A Phase 1/2 Study of Motolimod (VTX-2337) and MEDI4736 in Women with Recurrent, Platinum-Resistant Ovarian Cancer for Whom Pegylated Liposomal Doxorubicin (PLD) Is Indicated
- A Phase Ib Study of OMP-54F28 with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
- A Phase III Study of Doxil Alone and with Yondelis (Trabectedin) in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Clinical Trials Co-Investigated by Roisin E. O'Cearbhaill
- A Phase I Study of Genetically Engineered T Cells (CAR T Cells) to Treat Mesothelioma and Malignant Pleural Disease from Lung and Breast Cancers
- A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer